Skip to content
Grochi · Neutral pet information from South Korea · English edition한국어
Grochi.English edition
Veterinary medicines

Isoxazolines

Korean label term: 이속사졸린 계열 · Also called: isoxazoline, isoxazolines, afoxolaner, fluralaner, sarolaner, lotilaner

Translated from the Korean edition · Editorial draft, not professionally reviewed. This page is an English translation of the Korean edition as checked on 2026-11-22. If the two differ, the Korean edition is the reference. 한국어판 (Korean edition)

Definition

The isoxazolines (이속사졸린 계열) are a group of external antiparasitic ingredients including afoxolaner, fluralaner, sarolaner and lotilaner, for which the FDA gives guidance on neurologic adverse reactions.

About Isoxazolines

The isoxazolines (이속사졸린 계열) are a group of ingredients used in flea and tick products for dogs and cats. The small-animal ectoparasiticide entry of the Merck Veterinary Manual states that afoxolaner, fluralaner, lotilaner and sarolaner belong to this class, and explains that, as GABA-gated chloride channel antagonists, they overexcite the nervous system of insects and arachnids and quickly kill external parasites. The targets are described as broad, covering various insects, ticks and mange mites.

Forms differ by ingredient. The same entry lists afoxolaner as an oral chewable tablet for dogs; fluralaner as an oral product for dogs and a spot-on product for dogs and cats; lotilaner as an oral tablet for dogs (and for cats in some countries); and sarolaner as an oral chewable tablet for dogs and a spot-on combination product with selamectin for cats. A US FDA guidance document lists tablets, chewable tablets and topical solutions among the approved products of this class, and states that combination products with ingredients such as moxidectin, pyrantel and praziquantel are also included.

The caution is in the FDA guidance. The FDA states that products of this class have been associated with "neurologic adverse reactions, including muscle tremors, ataxia, and seizures in some dogs and cats", and advises that "seizures may occur in animals without a prior history". The same document also states that the FDA considers products of this class safe and effective for dogs and cats. The FDA's guidance is to talk with a veterinarian first if an abnormality occurs. If tremors, stumbling or seizures appear, go to an animal hospital or emergency care right away.

On regulation, the FDA consumer guide states that flea and tick products that are eaten or injected are approved by the FDA as animal drugs. The product list in the FDA document above also includes topical solution products. This term does not set a dose or an interval and does not recommend a product or ingredient. This entry is an editorial draft and professional review has not been completed.

How it appears on labels

Isoxazolines on labels
On Korean labels동물용의약품 포장의 유효성분란에 아폭솔라너·플루랄라너·사롤라너·로틸라너 같은 개별 성분명으로 적힌다. 계열 이름이 표시에 따로 적히지는 않는다. (Written by individual ingredient names such as afoxolaner, fluralaner, sarolaner and lotilaner in the active ingredient column of veterinary drug packaging; the class name is not written separately on the label.)
On English labelsOn overseas labels it is written as afoxolaner, fluralaner, sarolaner, lotilaner and so on, and the class is called isoxazoline.
Unit / basisNot applicable

Which standard is it?

  • US FDA Center for Veterinary Medicine fact sheet (isoxazoline flea and tick products): Lists neurologic adverse reactions including muscle tremors, ataxia and seizures, and advises that seizures may occur in animals without a prior history.
  • Merck Veterinary Manual (ectoparasiticides in small animals): States that afoxolaner, fluralaner, lotilaner and sarolaner are GABA-gated chloride channel antagonists with broad activity and come in oral and spot-on forms.

Common misconceptions

  • An animal with no history of seizures does not need to be a concern → The FDA guidance states that seizures may occur in animals without a prior history.
  • All oral flea products are the same ingredient → The Merck manual states that even within the isoxazoline class, the oral and spot-on forms and the target animals differ by ingredient.

What to check on the label

  • Check in the active ingredient column of the package whether an isoxazoline-class ingredient is present, and whether it is a combination product mixed with moxidectin, pyrantel and so on.
  • If the animal has a history of seizures or nerve signs, talk with a veterinarian before use. The FDA guidance document states to consult a veterinarian first if an abnormality occurs.
  • If muscle tremors, stumbling or seizures appear after giving it, go to an animal hospital or emergency care right away.

Related guides

Where was this checked?

Translated from the Korean edition · Editorial draft, not professionally reviewed. The Korean entry is an explainer newly written from these sources, not a full translation of them. Not a diagnosis, prescription or feeding instruction. Korean edition checked 2026-11-22 · no paid partnerships.

All glossary terms